CRT 2023
CTO Academy
Farouc A. Jaffer, MD, PhD (he/him/his)
Director Coronary Intervention and CTO PCI Program
Massachusetts General Hospital / Harvard Medical School
Boston, Massachusetts, United States
Disclosure(s): Abiomed: Honoraria (Ongoing); Asahi Intecc, Japan: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scientific: Consultant (Ongoing), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Scientific Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Canon Medical Systems USA, Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Royalties (Ongoing); DurVena Inc: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); HeartFlow Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); IMDS: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Intravascular Imaging Incorporated: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Massachusetts General Hospital: Patent Holder (Ongoing), Royalties (Ongoing), University Grants/Research Support (Ongoing); mercator: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Shockwave Medical, Inc.: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Siemens: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Spectrawave: Royalties (Ongoing); Teleflex Inc: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)